ARTICLE | Company News
Oxford BioMedica, Centre for Applied Microbiology and Research deal
May 8, 2000 7:00 AM UTC
OXB acquired exclusive global rights to a series of genes isolated by CAMR that encode nitroreductase enzymes. OXB will combine the enzymes with its gene delivery methods to produce a prodrug activati...